Drug
Sivelestat clinical trials
Keep track of what changes. Save the sivelestat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Sivelestat
- 4
Studies by the year they started
5 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 4
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1) · Eli Lilly and Company (1) · Assistance Publique - Hôpitaux de Paris (1) · Nanjing Medical University (1) · Beijing Tiantan Hospital (1)
Often tested with
Tested in the same studies.
Tocilizumab (1) · Baricitinib (1) · Interleukin 1 Receptor Antagonist Protein (1) · Hydrocortisone (1) · Fludrocortisone (1) · Heparin (1) · Heparin, Low-Molecular-Weight (1) · Interferon gamma-1b (1)
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses sivelestat is read from its arms, and is right about nine times in ten.
Testing it · 5
- Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT06381661Written as Sivelestat
- Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)RecruitingNot applicableNanjing Medical UniversityNCT06195267Written as Sivelestat
- Efficacy and Safety of Sivelestat in Preventing Postoperative Acute Lung Injury or Acute Respiratory Distress Syndrome After Cardiac SurgeryCompletedPhase 3The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT06276569Written as Sivelestat
- Sivelestat for Acute Respiratory Distress Syndrome Due to COVID-19Status unknownNot applicableBeijing Tiantan HospitalNCT05697016Written as Sivelestat Sodium for Injection
- A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung InjuryCompletedPhase 1/2Eli Lilly and CompanyNCT00036062Written as Sivelestat
Codes
What other systems call sivelestat · ClinicalTrials.gg INT003571
- MeSH (NLM) C069195sivelestatConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) DWI62G0P59SIVELESTATConfirmed FDA, NLM, Wikidata
- Wikidata Q5646925sivelestatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66539SivelestatOne source FDA
- DrugBank DB12863One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C069195 | sivelestat | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | DWI62G0P59 | SIVELESTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5646925 | sivelestat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66539 | Sivelestat | One source FDA |
| DrugBank | DB12863 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.